Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy.
Saved in:
| Title: | Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy. |
|---|---|
| Authors: | Huang C; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Cheng CS; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Shen Y; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. yehuash25@163.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. yehuash25@163.com., Chen H; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Lin J; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Hua Y; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Feng L; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Wu C; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Wang P; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Chen Z; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Meng Z; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. mengshca@fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. mengshca@fudan.edu.cn. |
| Source: | BMC cancer [BMC Cancer] 2024 Aug 02; Vol. 24 (1), pp. 941. Date of Electronic Publication: 2024 Aug 02. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
